Last reviewed · How we verify

NCT06316050

Retrovertion Assesment and Study in Elderly Patients With Reverse Total Shoulder Arthroplasty

Completed NA Last updated 18 March 2024
What this trial tests

NA trial testing humeral retroversion in Rotator Cuff Tears in 60 participants. Completed in 28 June 2023.

Timeline
1 August 2018
Primary endpoint
31 August 2021
28 June 2023

Quick facts

Lead sponsorConsorci Sanitari de Terrassa
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date1 August 2018
Primary completion31 August 2021
Estimated completion28 June 2023
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Consorci Sanitari de Terrassa — full company profile →

Who can join

60 and older, any sex, with Rotator Cuff Tears or Rotator Cuff Tear Arthropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Determine the optimal degree of retroversion (0-30º) to obtain the best rotational mobility, both internal and external, of the shoulder after implanting a reversed sghoulder arthroplasty (Comprehensive system), and analyze the functional and radiologic results based on humeral retroversion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Rotator Cuff Tears

Currently open trials in the same condition.

Other Consorci Sanitari de Terrassa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06316050.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing